Bionano Genomics, Inc. (BNGO) stock
BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)
Close on Nov 17, 2026Market cap $11.21MP/E –Yield –
Bionano Genomics operating margin
Operating margin is operating income as a percentage of revenue.
Bionano Genomics's operating margin for the twelve months ending Jun 30, 2026 was -106.7%. For fiscal 2025 it was -116.9%, against -337.9% the year before. The highest annual figure on record is -116.9% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -116.9% | +220.9 |
| FY2024 | Dec 31, 2024 | -337.9% | +258.1 |
| FY2023 | Dec 31, 2023 | -596.0% | −122.3 |
| FY2022 | Dec 31, 2022 | -473.7% | −44.9 |
| FY2021 | Dec 31, 2021 | -428.8% | +24.6 |
| FY2020 | Dec 31, 2020 | -453.4% | −197.9 |
| FY2019 | Dec 31, 2019 | -255.4% | −85.3 |
| FY2018 | Dec 31, 2018 | -170.1% | +74.2 |
| FY2017 | Dec 31, 2017 | -244.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -88.3% | +27.5 |
| Q1 FY2026 | Mar 31, 2026 | -118.1% | +13.0 |
| Q4 FY2025 | Dec 31, 2025 | -107.4% | +38.9 |
| Q3 FY2025 | Sep 30, 2025 | -115.9% | +607.0 |
| Q2 FY2025 | Jun 30, 2025 | -115.8% | +103.1 |
| Q1 FY2025 | Mar 31, 2025 | -131.1% | +223.8 |
| Q4 FY2024 | Dec 31, 2024 | -146.3% | +86.5 |
| Q3 FY2024 | Sep 30, 2024 | -722.9% | +492.1 |
| Q2 FY2024 | Jun 30, 2024 | -219.0% | +234.0 |
| Q1 FY2024 | Mar 31, 2024 | -354.9% | +155.4 |
| Q4 FY2023 | Dec 31, 2023 | -232.7% | +224.1 |
| Q3 FY2023 | Sep 30, 2023 | -1215.0% | −769.8 |
| Q2 FY2023 | Jun 30, 2023 | -453.0% | +28.0 |
| Q1 FY2023 | Mar 31, 2023 | -510.4% | +15.3 |
| Q4 FY2022 | Dec 31, 2022 | -456.8% | −0.1 |
| Q3 FY2022 | Sep 30, 2022 | -445.2% | −1.0 |
| Q2 FY2022 | Jun 30, 2022 | -480.9% | −53.7 |
| Q1 FY2022 | Mar 31, 2022 | -525.7% | −173.3 |
| Q4 FY2021 | Dec 31, 2021 | -456.7% | −177.9 |
| Q3 FY2021 | Sep 30, 2021 | -444.2% | +21.5 |
| Q2 FY2021 | Jun 30, 2021 | -427.3% | +201.7 |
| Q1 FY2021 | Mar 31, 2021 | -352.4% | +507.0 |
| Q4 FY2020 | Dec 31, 2020 | -278.8% | −22.1 |
| Q3 FY2020 | Sep 30, 2020 | -465.7% | −294.1 |
| Q2 FY2020 | Jun 30, 2020 | -629.0% | −314.4 |
| Q1 FY2020 | Mar 31, 2020 | -859.3% | −525.5 |
| Q4 FY2019 | Dec 31, 2019 | -256.7% | −104.8 |
| Q3 FY2019 | Sep 30, 2019 | -171.6% | +39.4 |
| Q2 FY2019 | Jun 30, 2019 | -314.7% | −196.3 |
| Q1 FY2019 | Mar 31, 2019 | -333.8% | −88.6 |
| Q4 FY2018 | Dec 31, 2018 | -151.9% | +32.2 |
| Q3 FY2018 | Sep 30, 2018 | -211.0% | −27.6 |
| Q2 FY2018 | Jun 30, 2018 | -118.4% | – |
| Q1 FY2018 | Mar 31, 2018 | -245.2% | – |
| Q4 FY2017 | Dec 31, 2017 | -184.2% | – |
| Q3 FY2017 | Sep 30, 2017 | -183.4% | – |
See a number that looks wrong?